NCT05172349

Phase 2Interventional

Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.

View on ClinicalTrials.gov ↗

Timeline

Start date: Apr 30, 2022
Primary completion: Sep 30, 2022
Completion date: Sep 30, 2022
First posted: Dec 29, 2021
Last posted: Aug 5, 2022
Enrollment: 0
Arms / groups: 1 / —
Source: AACT · ctgov ingestion

Drugs studied

amniotic membrane

Indications studied

Corneal Diseases
Corneal Ulcer

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.

NCT05172349

Timeline

Sponsors

Drugs studied

Indications studied